These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15567876)

  • 21. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can we eliminate severe ovarian hyperstimulation syndrome? Not completely.
    Buckett W; Chian RC; Tan SL
    Hum Reprod; 2005 Aug; 20(8):2367; author reply 2367-8. PubMed ID: 16024544
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.
    Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
    Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis.
    Crochet JR; Yeh JS; Clowse ME; Copland SD
    Fertil Steril; 2011 Apr; 95(5):1786.e13-6. PubMed ID: 21168129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian hyperstimulation syndrome: a clinical retrospective study on 565 inpatients.
    Du DF; Li MF; Li XL
    Gynecol Endocrinol; 2020 Apr; 36(4):313-317. PubMed ID: 31429334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian hyperstimulation syndrome and thrombotic events.
    Mor YS; Schenker JG
    Am J Reprod Immunol; 2014 Dec; 72(6):541-8. PubMed ID: 25146913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we eliminate severe ovarian hyperstimulation syndrome? Comment 2.
    De Neubourg D; Gerris J
    Hum Reprod; 2005 Aug; 20(8):2369; author reply 2369-70. PubMed ID: 16024547
    [No Abstract]   [Full Text] [Related]  

  • 31. Migraines and ovarian hyperstimulation syndrome: a dopamine connection.
    Rollene NL; Khan Z; Schroeder DR; Cutrer FM; Coddington CC
    Fertil Steril; 2011 Jan; 95(1):417-9. PubMed ID: 20889153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures.
    Aboulghar MA; Mansour RT
    Hum Reprod Update; 2003; 9(3):275-89. PubMed ID: 12859048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian hyperstimulation syndrome: a preventable syndrome?
    Rosenwaks Z; Benadiva C
    Semin Reprod Med; 2010 Nov; 28(6):437-9. PubMed ID: 21082500
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ovarian hyperstimulation syndrome].
    Le Gouez A; Naudin B; Grynberg M; Mercier FJ
    Ann Fr Anesth Reanim; 2011 Apr; 30(4):353-62. PubMed ID: 21398079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian hyperstimulation syndrome: definition, incidence, and classification.
    Zivi E; Simon A; Laufer N
    Semin Reprod Med; 2010 Nov; 28(6):441-7. PubMed ID: 21082501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.
    Orvieto R
    J Ovarian Res; 2013 Nov; 6(1):77. PubMed ID: 24191960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can we eliminate severe ovarian hyperstimulation syndrome? Comment I.
    Manno M
    Hum Reprod; 2005 Aug; 20(8):2368-9; author reply 2369-70. PubMed ID: 16024545
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.